Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

BCS
Home/The Filing Wire/Kardigan, Inc./ 4

Changes in Beneficial Ownership · 4

Kardigan, Inc.

KARDNASDAQEQUITYCurrent

Changes in Beneficial Ownership

Filed Jun 24, 2026Accepted Jun 24, 2026, 4:20 PM EDTCIK 2123613Accession 0001012975-26-000565
View company →Permanent SEC source ↗
Share

Company context

Kardigan is a clinical-stage precision therapeutics company developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist. Our mission is to develop multiple targeted cardiovascular treatments in parallel that bring people with cardiovascular diseases closer to the cures they deserve. We leverage deep domain expertise in cardiovascular biology, patient data, and advanced analytics to accelerate drug discovery and development, aiming to deliver impactful therapies efficiently and at scale.

Current securities

KARDNASDAQ · EQUITY · Current

Recent company filings

  1. SCHEDULE 13D/A - filed by PERCEPTIVE ADVISORS LLC regarding Kardigan, Inc.Oct 1, 2026
  2. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD DisclosureSep 30, 2026
  3. SCHEDULE 13G - filed by Edelberg Jay regarding Kardigan, Inc.Aug 13, 2026
  4. 10-Q filingAug 11, 2026
  5. Results of Operations and Financial ConditionAug 11, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.